State of Wyoming’s Xeris Biopharma Holdings XERS Stock Holding History

State of Wyoming’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.9K	Sell	6,556 -3,864	-37%	-$24.7K	0.01%	1686
2026 Q1	$60.4K	Sell	10,420 -32,038	-75%	-$212K	0.01%	1489
2025 Q4	$333K	Buy	42,458 +29,558	+229%	+$233K	0.04%	647
2025 Q3	$105K	Sell	12,900 -22,306	-63%	-$148K	0.01%	1293
2025 Q2	$164K	Buy	+35,206	New	+$161K	0.02%	1044
2022 Q2	–	Sell	-19,836	Closed	-$51K	–	2167
2022 Q1	$51K	Buy	19,836 +12,125	+157%	+$29.6K	0.03%	1050
2021 Q4	$23K	Buy	+7,711	New	+$16.7K	0.01%	1433

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State of Wyoming's XERS Position: Q2 2026 in Review

State of Wyoming reduced its Xeris Biopharma Holdings (XERS) stake by 37% in Q2 2026, selling an estimated $24.7K and leaving 6,556 shares worth $51.9K. The position accounts for 0.01% of the portfolio, ranked #1686.

State of Wyoming first reported a position in XERS in Q4 2021 and has held it in 7 quarters since. The position peaked at $333K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

State of Wyoming held 6,556 shares of Xeris Biopharma Holdings worth $51.9K as of Q2 2026.
State of Wyoming sold 3,864 Xeris Biopharma Holdings shares in Q2 2026, an estimated $24.7K.
Xeris Biopharma Holdings made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1686 holding.
State of Wyoming first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 7 quarters since.
State of Wyoming's Xeris Biopharma Holdings position peaked at $333K in Q4 2025.
240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.